Results 111 to 120 of about 830 (135)
Some of the next articles are maybe not open access.
Gastric Pentadecapeptide BPC 157 and Short Bowel Syndrome in Rats
Digestive Diseases and Sciences, 2008The gastric pentadecapeptide BPC 157, which was shown to be safe as an antiulcer peptide in trials for inflammatory bowel disease (PL14736, Pliva), successfully healed intestinal anastomosis and fistula in rat. Therefore, we studied for 4 weeks rats with escalating short bowel syndrome and progressive weight loss after small bowel resection from fourth
Sever, Marko +16 more
openaire +4 more sources
Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157
Current Medicinal Chemistry, 2012Stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, M.W. 1419) may be the new drug stable in human gastric juice, effective both in the upper and lower GI tract, and free of side effects. BPC 157, in addition to an antiulcer effect efficient in therapy of inflammatory bowel disease (IBD) (PL 14736) so far only tested in clinical phase II, has a ...
P, Sikiric +15 more
openaire +2 more sources
Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury
Regulatory Peptides, 2010We focused on the healing of rat transected sciatic nerve and improvement made by stable gastric pentadecapeptide BPC 157 (10 microg, 10ng/kg) applied shortly after injury (i) intraperitoneally/intragastrically/locally, at the site of anastomosis, or after (ii) non-anastomozed nerve tubing (7 mm nerve segment resected) directly into the tube ...
Gjurašin, Miroslav +9 more
openaire +2 more sources
Antiinflammatory effect of BPC 157 on experimental periodontitis in rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2009The pentadecapeptide BPC 157 has been shown to have anti-inflammatory and wound healing effects on multiple target tissues and organs. The purpose of the present study was to investigate the effect of BPC 157 on inflammation and bone resorption in experimental periodontitis in rats.
Kerémi, B. +11 more
openaire +2 more sources
Traumatic brain injury in mice and pentadecapeptide BPC 157 effect
Regulatory Peptides, 2010Gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, an anti-ulcer peptide, efficient in inflammatory bowel disease trials (PL 14736), no toxicity reported, improved muscle crush injury. After an induced traumatic brain injury (TBI) in mice by a falling weight, BPC 157 regimens (10.0microg, 10.0ng/kgi.p.) demonstrated a marked attenuation of damage with ...
Tudor, Mario +11 more
openaire +3 more sources
The Role of Pentadecapeptide BPC 157 in angiogenesis and NO-synthesis
1997A clear protection of G-I tract and an evident anti-inflammatory effect were shown for a novel stomach pentadecapeptide BPC(i.p./i.g.) in comparison with several reference standards in various ulcer models alog with a protection of endothelium. Thus, in the first experiments we evaluated whether this pentadecapeptide and other gastroprotective agents ...
Sikirić, Predrag +18 more
openaire +2 more sources
The pharmacological properties of the novel peptide BPC 157 (PL-10)
Inflammopharmacology, 1999The reported beneficial effects of the gastric mucosal derived pentadecapeptide BPC 157 (Gly Glu Pro Pro Pro Gly Lys Pro Ala Asp Asp Ala Gly Leu Val, M.W. 1419) on different organ lesions are reviewed. Apart from the effects on various gastrointestinal lesions, the potentially beneficial effect on pancreas, liver injuries, endothelium and heart damage,
openaire +2 more sources
Protuupalni učinak pentadekapeptida BPC 157
1998U svim istraživanim upalnim modelima, karageninski edem šape - model akutne upale, terpentinski bukalni edem - model subakutne upale i adjuvantni artritis model kronične upale, BPC 157 je pokazao izrazito protuupalno djelovanje. U karageninskom upalnom modelu BPC 157 dovodi do značajnog smanjenja edema, a učinak je sličan učinku acetilsalicilne ...
openaire +1 more source

